6don MSNOpinion
Why 2026 is biotech’s comeback year
Headwinds in the sector are clearing. That is good news for venture firms seeking liquidity and for a stock market looking ...
The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Incubate Founder and Executive Director John Stanford spent a busy day on Capitol Hill this week making the case that the ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...
The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...
John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...
For most students, science is limited to the lab bench — pipetting solutions and taking precise measurements to check the validity of their hypothesis. Yet, beyond the world of the wet lab, quietly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results